Most of the time, psoriasis is the first symptom of psoriatic arthritis. It causes silvery-white skin lesions called plaques, which may appear on your scalp, elbows, knees, and lower back. Eventually, ...

in which side effects are monitored and effectiveness is compared to similar drugs on the market BCD-085, or Patera, is a biologic and type of monoclonal antibody being tested for people with ...

Biologics are given by injection or infusion. There are several categories of these drugs: Acthar gel (repository ... for ...

The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included TNFi (n = 20,314), IL-17i (n = 5,073), IL ...

PsA often coexists with a range of comorbidities, which can complicate treatment decisions. By tailoring treatment strategies, clinicians can improve outcomes for their patients.

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Psoriatic arthritis is an autoimmune condition. It happens when your body’s immune system attacks healthy tissue by mistake.

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

compared apremilast with placebo in patients with active psoriatic arthritis despite prior traditional disease-modifying antirheumatic drug (DMARD) and/or biologic therapy. Methods In the 24-week, ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...